ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
WT1 Protein-derived Peptide Vaccine DSP-7888
Mapping Intimacies
◽
10.32388/b0yk3m
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
◽
Wt1 Protein
Download Full-text
Related Documents
Cited By
References
Antitumor effect of oral cancer vaccine withBifidobacteriumdelivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
Human Vaccines & Immunotherapeutics
◽
10.1080/21645515.2017.1382787
◽
2017
◽
Vol 14
(1)
◽
pp. 159-162
◽
Cited By ~ 6
Author(s):
Toshiro Shirakawa
◽
Koichi Kitagawa
Keyword(s):
Immune System
◽
Oral Cancer
◽
Cancer Vaccine
◽
Antitumor Effect
◽
Peptide Vaccine
◽
Gut Immune System
◽
Wt1 Protein
Download Full-text
MAGE-3 Peptide Vaccine
10.32388/2z9283
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
Download Full-text
HIV Peptide Vaccine
10.32388/d79ig0
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
Download Full-text
MART-1:27-35 Peptide Vaccine
10.32388/jwh3cn
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
Download Full-text
Melanoma Helper Peptide Vaccine
10.32388/pf3w95
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
◽
Helper Peptide
Download Full-text
Telomerase: 540-548 Peptide Vaccine
10.32388/sy3yi5
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
Download Full-text
NA17.A2 Peptide Vaccine
10.32388/uw4s50
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
Download Full-text
Berzofsky Ras/P53 Peptide Vaccine
10.32388/xa4lky
◽
2020
◽
Author(s):
Keyword(s):
Peptide Vaccine
Download Full-text
Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy
10.21236/ada566780
◽
2012
◽
Author(s):
Lee M. Krug
Keyword(s):
Phase Ii
◽
Malignant Pleural Mesothelioma
◽
Phase Ii Trial
◽
Peptide Vaccine
◽
Multimodality Therapy
◽
Pleural Mesothelioma
◽
Randomized Phase Ii
◽
Analog Peptide
Download Full-text
Randomized Phase II Trial of Adjuvant WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma after Completion of Multimodality Therapy
10.21236/ada592046
◽
2013
◽
Author(s):
Lee M. Krug
Keyword(s):
Phase Ii
◽
Malignant Pleural Mesothelioma
◽
Phase Ii Trial
◽
Peptide Vaccine
◽
Multimodality Therapy
◽
Pleural Mesothelioma
◽
Randomized Phase Ii
◽
Analog Peptide
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close